Medirom Healthcare Reports July 2024 KPIs

Ticker: MRM · Form: 6-K · Filed: Aug 27, 2024 · CIK: 1819704

Sentiment: neutral

Topics: kpi-update, foreign-private-issuer, press-release

TL;DR

Medirom dropped July KPIs on 8/27, check the 6-K for operational updates.

AI Summary

Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for July 2024 via a press release on August 27, 2024. The filing is a Form 6-K, reporting information for foreign private issuers. The company is based in Tokyo, Japan, and operates in the personal services sector.

Why It Matters

This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing for a timely assessment of the company's performance in July 2024.

Risk Assessment

Risk Level: low — This is a routine filing providing operational updates and does not contain significant new financial information or strategic changes.

Key Players & Entities

FAQ

What specific Key Performance Indicators (KPIs) are being updated for July 2024?

The filing states that the press release announces "major Key Performance Indicators, or KPIs, updated for the month of July 2024," but the specific KPIs are not detailed within the provided text of the 6-K itself, only that they are in Exhibit 99.1.

When was the press release announcing the July 2024 KPIs issued?

The press release announcing the July 2024 KPIs was issued on August 27, 2024.

What is the purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.

Where is Medirom Healthcare Technologies Inc. headquartered?

Medirom Healthcare Technologies Inc. is headquartered at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.

Does this filing include annual report information?

No, this filing is a Form 6-K, and the company indicates it files annual reports under cover of Form 20-F, not this form.

Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-08-27 06:00:48

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 27, 2024 MEDIROM HEALTHCARE TECHNOLOGIES INC. By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing